BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24964703)

  • 21. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethical analysis to improve decision-making on health technologies.
    Saarni SI; Hofmann B; Lampe K; Lühmann D; Mäkelä M; Velasco-Garrido M; Autti-Rämö I
    Bull World Health Organ; 2008 Aug; 86(8):617-23. PubMed ID: 18797620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Making sensible rationing: the use of economic evidence and the need for methodological standards.
    Tangcharoensathien V; Kamolratanakul P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S4-7. PubMed ID: 19253481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based decision-making 3: Health technology assessment.
    O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
    Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
    Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to introduce more (or better) ethical arguments in HTA?
    Schokkaert E
    Int J Technol Assess Health Care; 2015 Jan; 31(3):111-2. PubMed ID: 26044817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation of economic evaluation results.
    Chaikledkaew U
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S72-80. PubMed ID: 24964702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.
    Aryankhesal A; Behzadifar M; Bakhtiari A; Shahabi S; Azari S; Darvishi Teli B; Rezapour A; Ehsanzadeh SJ; Behzadifar M
    Health Res Policy Syst; 2024 Jan; 22(1):11. PubMed ID: 38225573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social values and health priority setting in Australia: an analysis applied to the context of health technology assessment.
    Whitty JA; Littlejohns P
    Health Policy; 2015 Feb; 119(2):127-36. PubMed ID: 25267072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
    ; Neumann PJ; Drummond MF; Jönsson B; Luce BR; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2010 Jan; 26(1):71-8. PubMed ID: 20059783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-criteria development and incorporation into decision tools for health technology adoption.
    Poulin P; Austen L; Scott CM; Waddell CD; Dixon E; Poulin M; Lafrenière R
    J Health Organ Manag; 2013; 27(2):246-65. PubMed ID: 23802401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health technology assessment in India: the potential for improved healthcare decision-making.
    Kumar M; Ebrahim S; Taylor FC; Chokshi M; Gabbay J
    Natl Med J India; 2014; 27(3):159-63. PubMed ID: 25668089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES.
    Daniels N; van der Wilt GJ
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):10-5. PubMed ID: 27472157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review.
    Assasi N; Schwartz L; Tarride JE; Campbell K; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):203-20. PubMed ID: 24625039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
    Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
    Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.